Clinical Trial Update: Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels

View source ↗

Summary

Dexamethasone reduces postoperative emesis by lowering PGF2α and LTC4 levels, according to a trial update involving thyroid and breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Thyroid Cancer

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Marmara University | Conditions: Thyroid Cancer, Breast Cancer | Status: UNKNOWN